KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Asset Utilization Ratio: 2018-2024

Historic Asset Utilization Ratio for Aquestive Therapeutics (AQST) over the last 7 years, with Dec 2024 value amounting to 0.01.

  • Aquestive Therapeutics' Asset Utilization Ratio fell 119.76% to 0.10 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.10, marking a year-over-year decrease of 119.76%. This contributed to the annual value of 0.01 for FY2024, which is 98.56% down from last year.
  • As of FY2024, Aquestive Therapeutics' Asset Utilization Ratio stood at 0.01, which was down 98.56% from 0.88 recorded in FY2023.
  • Aquestive Therapeutics' Asset Utilization Ratio's 5-year high stood at 0.88 during FY2023, with a 5-year trough of 0.01 in FY2024.
  • Over the past 3 years, Aquestive Therapeutics' median Asset Utilization Ratio value was 0.80 (recorded in 2022), while the average stood at 0.57.
  • In the last 5 years, Aquestive Therapeutics' Asset Utilization Ratio skyrocketed by 1,338.57% in 2021 and then tumbled by 98.56% in 2024.
  • MRY analysis of 5 years shows Aquestive Therapeutics' Asset Utilization Ratio stood at 0.06 in 2020, then surged by 1,338.57% to 0.81 in 2021, then fell by 1.62% to 0.80 in 2022, then increased by 10.33% to 0.88 in 2023, then crashed by 98.56% to 0.01 in 2024.
  • Its Asset Utilization Ratio was 0.01 in FY2024, compared to 0.88 in FY2023 and 0.80 in FY2022.